Brief: Newron Pharmaceuticals Evenamide Pre-Clinical Studies Completed
11/08/2020 06:10
Aug 11 (Reuters) - NEWRON PHARMACEUTICALS SPA NWRN.S :
* ALL EVENAMIDE PRE-CLINICAL STUDIES REQUESTED BY FDA
COMPLETED
AND FIRST CLINICAL SAFETY STUDY INITIATED; ON TRACK TO INITIATE
EVENAMIDE
* PHASE III PROGRAM IN 2021
Source text for Eikon: ID:nEQXBbMma
Further company coverage: NWRN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Newron Pharmaceuticals SpA
See all newsUS FDA flags four deaths in Newron's schizophrenia drug studies (updated)
US FDA cites 4 deaths in Newron's schizophrenia drug trial hold
Brief: Newron Says Topline Data From ENIGMA-TRS 1 Expected In Q1 2027
Brief: Newron Provides Update Following Type A Meeting With The FDA
Brief: Newron Reports Pause Of Enrollment Of New Study Participants In US Centers Of ENIGMA-TRS 2 Study